LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214Chen Ying, Wenxin Liu, Hui Du et al.|Cancer Biology and Medicine|2018Cited by 100
Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II studyJindong Sheng, Wenxin Liu, Xiangyu Liu et al.|Signal Transduction and Targeted Therapy|2025Cited by 15
Phenethyl isothiocyanate suppresses cervical carcinoma metastasis potential and its molecular mechanismLi Zhang, Huijuan Wu, Quan Hao et al.|Molecular Medicine Reports|2014Cited by 14